Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Biogen (BIIB) Set To Gap Up 40% On Earnings/Drug News

FYI: Biogen (BIIB) shares are currently set to gap higher by 41% this morning due to earnings and positive news for its Alzheimer's drug. A 40%+ gap on earnings is extremely rare, but we can find historical occurrences very easily using our Earnings Explorer tool. Seeing how prior stocks performed following big gaps up or down on earnings is one of the many useful ways to use our Earnings Explorer. Below are the results from a quick screen we ran that found all stocks reporting earnings since the start of 2017 that opened higher by at least 40% on the day. As shown, there have only been 12 occurrences, and the average gap up at the open for these 12 names was +65.27%.
Regards,
Ted
https://www.bespokepremium.com/interactive/posts/think-big-blog/biogen-biib-set-to-gap-up-40-on-earnings-drug-news

M* Ownership:
https://www.morningstar.com/stocks/xnas/biib/ownership
Sign In or Register to comment.